share_log

BioVie | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Terren S. Peizer(44.53%),Acuitas Group Holdings, LLC(44.47%)

BioVie | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Terren S. Peizer(44.53%),Acuitas Group Holdings, LLC(44.47%)

BioVie | SC 13D/A:超过5%持股股东披露文件(修正)-Terren S. Peizer(44.53%),Acuitas Group Holdings, LLC(44.47%)
美股SEC公告 ·  2024/06/25 19:50

Moomoo AI 已提取核心信息

On June 21, 2024, Terren S. Peizer, associated with Acuitas Group Holdings, LLC, was found guilty of securities fraud and insider trading related to the sale of shares of Ontrak, Inc. The conviction is subject to appeal. This information was disclosed in an amendment to Schedule 13D filed with the SEC, which also reported that Acuitas and Mr. Peizer collectively hold a significant stake in BioVie Inc. As of June 25, 2024, Acuitas may be deemed to have beneficial ownership of 30,435,738 shares of BioVie's Common Stock, representing approximately 44.47% of the company. Mr. Peizer may be deemed to have beneficial ownership of 30,503,938 shares, representing about 44.53% of the outstanding Common Stock. These figures include shares that may be issued upon the exercise of a warrant and options that became fully vested and exercisable as of March 2, 2023. The filing confirms that there have been no transactions in the company's securities by the reporting persons in the past sixty days.
On June 21, 2024, Terren S. Peizer, associated with Acuitas Group Holdings, LLC, was found guilty of securities fraud and insider trading related to the sale of shares of Ontrak, Inc. The conviction is subject to appeal. This information was disclosed in an amendment to Schedule 13D filed with the SEC, which also reported that Acuitas and Mr. Peizer collectively hold a significant stake in BioVie Inc. As of June 25, 2024, Acuitas may be deemed to have beneficial ownership of 30,435,738 shares of BioVie's Common Stock, representing approximately 44.47% of the company. Mr. Peizer may be deemed to have beneficial ownership of 30,503,938 shares, representing about 44.53% of the outstanding Common Stock. These figures include shares that may be issued upon the exercise of a warrant and options that became fully vested and exercisable as of March 2, 2023. The filing confirms that there have been no transactions in the company's securities by the reporting persons in the past sixty days.
2024年6月21日,与Acuitas Group Holdings,LLC有关的Terren S.Peizer因与Ontrak,Inc的股份销售有关的证券欺诈和内幕交易被定罪。该定罪正在上诉中。这一信息是在向SEC提交的13D表格修正案中披露的,该表格还报告称,Acuitas和Peizer先生共同持有BioVie Inc的重要股份。 截至2024年6月25日,Acuitas可能被视为对BioVie的普通股拥有30,435,738股的有益所有权,约占公司的44.47%。Peizer先生可能被视为拥有30,503,938股有价证券,约占未流通的普通股的44.53%。这些数字包括可能在行使权利和于2023年3月2日获得完全行权和行使权利的期权时发行的股份。该提交确认报告人在过去六十天内没有对公司证券进行交易。
2024年6月21日,与Acuitas Group Holdings,LLC有关的Terren S.Peizer因与Ontrak,Inc的股份销售有关的证券欺诈和内幕交易被定罪。该定罪正在上诉中。这一信息是在向SEC提交的13D表格修正案中披露的,该表格还报告称,Acuitas和Peizer先生共同持有BioVie Inc的重要股份。 截至2024年6月25日,Acuitas可能被视为对BioVie的普通股拥有30,435,738股的有益所有权,约占公司的44.47%。Peizer先生可能被视为拥有30,503,938股有价证券,约占未流通的普通股的44.53%。这些数字包括可能在行使权利和于2023年3月2日获得完全行权和行使权利的期权时发行的股份。该提交确认报告人在过去六十天内没有对公司证券进行交易。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息